Female fertility
PCOS and pregnancy: ovulation induction, lifestyle and IVF
By Dr. Suresh Kattera · 16 min read · Published
Why PCOS Causes Fertility Challenges
In a normal ovulatory cycle, several ovarian follicles begin developing, but one dominant follicle is selected, matures, and releases an egg around Day 14.
In PCOS, hyperinsulinemia (insulin resistance) and elevated luteinizing hormone (LH) arrest follicular growth at an early antral stage (2–8 mm). The ovary accumulates numerous immature follicles ("string of pearls" appearance on ultrasound), none of which reach ovulatory maturity, causing irregular, delayed, or absent periods (oligomenorrhea or amenorrhea). Without ovulation, natural conception cannot occur.
Stepped Treatment Hierarchy: Lowest Intervention First
At Mysuru Fertility Centre, we adhere strictly to evidence-based fertility stepping:
- Metabolic & Lifestyle Optimization: Even a 5%–10% reduction in visceral body weight restores spontaneous regular ovulation in up to 50% of overweight PCOS women by lowering circulating insulin and free testosterone.
- First-Line Ovulation Induction (Letrozole): International clinical trials (including the landmark *NEJM* study) demonstrate that Letrozole (an aromatase inhibitor) achieves significantly higher ovulation rates (61.7% vs 48.3%) and live birth rates compared to clomiphene citrate, with a lower incidence of multiple pregnancies.
- Timed Intercourse with Follicular Ultrasound: Tracking follicle growth ensures intercourse occurs precisely during the 36-hour ovulatory window triggered by hCG.
- Intrauterine Insemination (IUI): Indicated if mild male factors coexist or if timed intercourse fails over 3–4 monitored cycles.
- IVF with Antagonist Protocol & Agonist Trigger (Zero-OHSS): If conservative treatments fail, IVF offers outstanding cumulative success rates (>75%), because women with PCOS typically possess abundant ovarian egg reserve.
Protecting Patient Safety: Zero-OHSS IVF Protocols
Women with PCOS are at elevated risk for Ovarian Hyperstimulation Syndrome (OHSS). In our Class-100 lab, we employ modern GnRH antagonist stimulation protocols paired with a GnRH agonist trigger (Decapeptyl/Lupride) and a mandatory "Freeze-All" strategy. This protocol reduces severe OHSS risk to virtually 0%, completely protecting patient health while optimizing uterine receptivity for a subsequent frozen embryo transfer.
Frequently asked questions
Untreated PCOS is associated with a modestly elevated early pregnancy loss rate, primarily driven by underlying insulin resistance, elevated LH levels, and sub-optimal endometrial receptivity. Optimizing insulin sensitivity (via Metformin and inositol supplements) and maintaining normal thyroid and prolactin levels prior to embryo transfer normalizes miscarriage rates.
Clinical guidelines recommend up to 4 to 6 ovulatory Letrozole cycles. If pregnancy is not achieved after 4 confirmed ovulatory cycles with adequate luteal progesterone, further diagnostic evaluation (such as tubal patency check or laparoscopy) and discussion of assisted reproduction are advised.